NCT00418769View on ClinicalTrials.gov

Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

August 31, 2006

Conditions
Healthy
Interventions
DRUG

Nilotinib

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY